Calithera Biosciences, Inc. reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported net loss was USD 69.21 million compared to USD 22.57 million a year ago. Basic loss per share from continuing operations was USD 18.4 compared to USD 6.4 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | 0.00% | 0.00% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 97.45K | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- CALA Stock
- News Calithera Biosciences, Inc.
- Calithera Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021